Because we had survival data from our patients, we calculated DFS and OS by taking the cutoff of ≥ 50% positive tumor cells as high expression of DLL3, as previously considered in MTC [14, 15]). This evidence concerns the gene DLL3 and medullary thyroid gland carcinoma.